已收录 268921 条政策
 政策提纲
  • 暂无提纲
The effect of NMDA receptor antagonism on cortical gamma power and synchronization in vivo
[摘要] Acute administration of NMDA receptor antagonists such as PCP and ketamine are accepted models of schizophrenia in rats. Oscillatory activity in the gamma range (30-120 Hz) is known to be increased in schizophrenia and by NMDA receptor antagonism. Putative links have been made between abnormal gamma activity and cognitive deficits that are known in schizophrenia. However, the site of action of these antagonists and how they modulate gamma \(in\) \(vivo\) remains unclear.In this study PCP was systemically injected into freely moving rats and ketamine systemically injected into terminally anaesthetised rats, whilst recording intracranial EEG activity in the prefrontal cortex, visual cortex and hippocampus. Ketamine was also administered locally into these same areas in anaesthetised rats and EEG activity recorded.1 mg/kg PCP significantly decreased performance in an associative learning task, significantly increased gamma power in all recording areas and decreased inter-area gamma synchronisation. 4 mg/kg ketamine also significantly increased gamma power and decreased inter-area synchronisation. Local injection of 5 μg/μl ketamine caused no significant changes to gamma power or inter-area synchronisation.The data presented in this study suggests that local NMDA receptor antagonism may not be the primary cause of changes to gamma activity that occurs following systemic treatments.
[发布日期]  [发布机构] University:University of Birmingham;Department:School of Clinical and Experimental Medicine
[效力级别]  [学科分类] 
[关键词] R Medicine;RC Internal medicine;RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry [时效性] 
   浏览次数:5      统一登录查看全文      激活码登录查看全文